Ambulatory Infusion Center (AIC) are gaining popularity once more, but not for the first time. AICs have been around for quite some time. They were popular at the end of the last century (1980s-90s), but were attacked by the same entities that are now looking to them to slay the cost dragon associated with site of service. Payers accused AICs of generating derived utilisation, i.e., self referral, back then. As a result, Ambulatory Infusion Centers (AIC) were met with a wall of contracting resistance from payers, but the unintended consequence was that spend shifted to the hospital outpatient department.
In the early 2000s, there was a resurgence of Ambulatory Infusion Center, but payers had yet to decide on a contracting strategy to control infusion delivery costs. As we enter the 2020s, AICs are regaining their lost lustre as payers finally get serious about moving patients to lower-cost sites of care.
Read more- https://cmi-latestreportorientedblogs.blogspot.com/2022/08/global-ambulatory-infusion-center.html
